maxwellt/fedgrantsembedded huggingface dataset:
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Agency: National Institutes of Health
Posted: 2024-03-22 | Closing date: 2026-08-25
Cost sharing or matching requirement: No

The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) encourages applications for Center Core grants (P30) to support HIV/AIDS Research Centers (ARC). The ARC is intended to provide infrastructure support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. This Notice of Funding Opportunity (NOFO) intends to support innovative, interdisciplinary research in several areas, including basic, NeuroHIV, behavioral and social, integrated biobehavioral, applied, clinical, translational, and implementation science.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.  Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.  Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
Agency: National Institutes of Health
Posted: 2024-03-22 | Closing date: 2024-07-26
Cost sharing or matching requirement: No

The purpose of this Notice Of Funding Opportunity (NOFO) is to solicit applications on the optimization and characterization of technologies and assays with the potential for utilization and adoption in regulatory submissions of genome editing therapeutics.

Eligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Combat human smuggling and Gender-Based Violence TIP and best practices in the Government of Guatemala for SVET
Agency: Bureau of International Narcotics-Law Enforcement
Posted: 2024-03-21 | Closing date: 2024-05-22
Award ceiling: 800000
Award floor: 780000
Expected number of awards: 1
Cost sharing or matching requirement: No

Gender based violence (GBV) in Guatemala has increased significantly during the pandemic and vulnerable populations including minors are among the victims. The Secretariat Against Sexual Violence, Exploitation, and Trafficking in Persons (SVET) of the Guatemalan Government is the entity with the mandate to ensure the coordination of the prevention, security, justice, welfare, and attention from local authorities to victims and create awareness of these crimes. Cultural awareness and crime prevention in Guatemala have been delegated to the National Civil Police (PNC). However, there are multiple institutions who work with SVET that need to take a more active role in addressing these crimes. The Ministry of Education (MINEDUC) is one of these stakeholders, who has the key responsibility of promoting positive values and addressing these kinds of issues with the next generation of Guatemalans. SVET has interinstitutional agreements between them and both MINEDUC and PNC to coordinate and collaborate in topics related to sexual violence, exploitation, and TIP.Standardize and strengthen SVET, with strong knowledge in sexual crimes, exploitation, trafficking in persons (TIP) and a capable train the trainer program to coordinate all the Government of Guatemala (GoG) institutions to conduct awareness campaigns to combat sexual and GBV by rejecting stereotypes and cultural norms that permit these crimes. In addition, empower SVET to identify and initiate through corresponding authorities investigations against criminal structures engaged in money laundering and human trafficking.

Eligibility: The following organizations are eligible to apply:U.S.-based non-profit/non-governmental organizations (NGOs);U.S.-based educational institutions subject to section 501(c)(3) of the U.S. tax code or section 26 US 115 of the US 115 of the U.S. tax code;Foreign-based non-profits/non-governmental organizations (NGOs);Foreign-based educational institutions
U.S. Embassy Paramaribo PAS Annual Program Statement
Agency: U.S. Mission to Suriname
Posted: 2024-03-22 | Closing date: 2024-06-01
Estimated total program funding: 15000
Award ceiling: 10000
Award floor: 5000
Expected number of awards: 3
Cost sharing or matching requirement: No

PAS Paramaribo invites proposals from NGOs, individuals and government educational institutions for programs that contribute to the improvement of social, economic or environmental conditions in Suriname and which further one or more of the priorities listed below. All programs must include a connection with American cultural element(s), expert(s), organization(s) or institution(s) that will promote increased understanding of U.S. policy, culture, and perspectives.Priority Program Areas Strengthening democracy – Promoting civic involvement, free and fair elections, or democratic governance at the local or national level in a non-partisan manner.Addressing climate change and environmental education – Nurturing efforts to mitigate and adapt to climate change and reduce food and water insecurity, particularly among underserved and vulnerable populations.Limiting Corruption - Supporting efforts to counter or prevent corruption in business or government, including efforts to develop greater fiscal transparency, enhance the rule of law, and/or protect intellectual property rights.Supporting a free and expressive media environment – Strengthening the professionalism of the media and/or advancing media literacy within the population.Advancing diversity, equality, inclusion, and accessibility for all marginalized communities – Addressing issues involving ethnicity, gender, sexual orientation, physical disabilities, and/or indigenous and tribal communities.Promoting academic linkages – Creating programs or exchanges designed to increase college and university professional linkages between the U.S. and Suriname, especially with community colleges and technical schools.Empowering women – Creating programs focused on the mentorship of women entrepreneurs and/or supporting women’s increased participation in civil society.Developing Alumni — Supporting programs led by, supported by, or involving the Suriname American Alumni Association, its members, or alumni of U.S. exchange programs.Enhancing agricultural production — Supporting efforts that advance understanding of modern agricultural practices and expanding entrepreneurship skills with the goal of increasing exports to U.S. and EU markets.Supporting cultural exchange — Hosting cultural performances, artistic workshops, trainings, and exhibitions that highlight the deep and ongoing ties between the United States and Suriname and our shared democratic values.

Eligibility: The Public Affairs Section encourages applications from U.S. and Surinamese:    Registered not-for-profit organizations, including think tanks and civil society/non-governmental organizations with programming experience;  Individuals;  Non-profit or governmental educational institutions;  Governmental institutions
Public Diplomacy
Urban Health Activity
Agency: Uganda USAID-Kampala
Posted: 2024-03-22 | Closing date: 2024-05-20
Estimated total program funding: 44000000
Award ceiling: 34000000
Expected number of awards: 1
Cost sharing or matching requirement: Yes

Notice of Funding Opportunity summary:The United States Agency for International Development (USAID) is seeking applications for aCooperative Agreement from qualified entities to implement the Urban Health Activity. Eligibilityfor this award is not restricted.USAID intends to make an award to the applicant who best meets the objectives of this fundingopportunity based on the merit review criteria described in SECTION E of this Notice of FundingOpportunity (NOFO), subject to a risk assessment. The applicant receiving an award will be the“Recipient”. Eligible parties interested in submitting an application are encouraged to read thisNOFO thoroughly to understand the type of program sought, application submissionrequirements, and selection process.Activity short summary:USAID/Uganda plans to award a five-year Cooperative Agreement to enhance health systemresilience and improve the survival and well-being of the residents of Kampala city, Mukono, andWakiso districts (hereafter referred to as the “Target Districts”) (the “Activity”). The Activity willstrengthen public and private health systems at the facility and community levels to deliverresponsive, timely, evidence-based, quality services. The Activity will strengthen maternal,newborn, and child health (MNCH); malaria; family planning (FP) / reproductive health (RH);nutrition; and Global Health Security (GHS) services in the Target Districts.

Notice of Funding Opportunity
Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation
Agency: National Science Foundation
Posted: 2024-03-23 | Closing date: 2024-06-21
Estimated total program funding: 5000000
Expected number of awards: 10
Cost sharing or matching requirement: No

The Foundations for Digital Twins as Catalyzers of Biomedical Technological Innovation (FDT-BioTech) program supports inherently interdisciplinary research projects that underpin the mathematical and engineering foundations behind the development and use of digital twins and synthetic data in biomedical and healthcare applications, with a particular focus on digital, in silico models used in the evaluation of medical devices and the relevance of the developed models in addressing current and emerging challenges affecting the development and assessment of biomedical technologies. The goal of the FDT-BioTech initiative is to catalyze biomedical technological innovation through new foundational development of methods and algorithms relevant to digital twins and synthetic humans.

Eligibility: *Who May Submit Proposals: Proposals may only be submitted by the following:   -Institutions of Higher Education (IHEs) - Two- and four-year IHEs (including community colleges) accredited in, and having a campus located in the US, acting      on behalf of their faculty members.Special Instructions for International Branch Campuses of US IHEs: If the proposal includes funding to be provided to an      international branch campus of a US institution of higher education (including through use of subawards and consultant arrangements), the proposer must explain      the benefit(s) to the project of performance at the international branch campus, and justify why the project activities cannot be performed at the US campus.
Mathematical Foundations of Digital Twins
Agency: National Science Foundation
Posted: 2024-03-23 | Closing date: 2024-06-20
Estimated total program funding: 5000000
Award floor: 1500000
Expected number of awards: 10
Cost sharing or matching requirement: No

The Division of Mathematical Sciences (DMS) in the Directorate for Mathematical and Physical Sciences (MPS) at the National Science Foundation (NSF) and the Air Force Office of Scientific Research (AFOSR) plan to jointly support foundational mathematical and statistical research on Digital Twins in applied sciences. Recent years have witnessed a significant increase in the demand and interest in applications that involve collaborative teams developing and analyzing Digital Twins to support decision making in various fields, including science, engineering, medicine, urban planning, and more. Both agencies recognize the need to promote research aiming to stimulate an interplay between mathematics/statistics/computation and practical applications in the realm of Digital Twins. This program encourages new collaborative efforts within the realm of Digital Twins, aiming at stimulating fundamental research innovation, pushing, and expanding the boundaries of knowledge, and exploring new frontiers in mathematics and computation for Digital Twin development, and its applications. By leveraging this synergy, the program aims to harness science, technology, and innovation to address some of our Society’s most pressing challenges.

Eligibility: *Who May Submit Proposals: Proposals may only be submitted by the following:   -Non-profit, non-academic organizations: Independent museums, observatories, research laboratories, professional societies and similar organizations located in the U.S. that are directly associated with educational or research activities.   -Institutions of Higher Education (IHEs) - Two- and four-year IHEs (including community colleges) accredited in, and having a campus located in the US, acting      on behalf of their faculty members.Special Instructions for International Branch Campuses of US IHEs: If the proposal includes funding to be provided to an      international branch campus of a US institution of higher education (including through use of subawards and consultant arrangements), the proposer must explain      the benefit(s) to the project of performance at the international branch campus, and justify why the project activities cannot be performed at the US campus.   -Tribal Nations: An American Indian or Alaska Native tribe, band, nation, pueblo, village, or community that the Secretary of the Interior acknowledges as a federally recognized tribe pursuant to the Federally Recognized Indian Tribe List Act of 1994, 25 U.S.C. §§ 5130-5131.
2024-FINAL-IFRP-TRANSPORT-RFA
Agency: Agency for International Development
Posted: 2024-03-25 | Closing date: 2024-06-05
Award ceiling: 351000
Award floor: 0
Expected number of awards: 14
Cost sharing or matching requirement: No

The United States Agency for International Development (USAID) Bureau for Humanitarian Assistance (BHA) is seeking applications for funding to support the rapid transportation, delivery, and distribution of shelf-stable, prepackaged commodities to be distributed under the International Food Relief Partnership (IFRP) program. Please refer to the Funding Opportunity Description for a complete description. Private voluntary organizations or cooperatives, including U.S. and non-U.S. nongovernmental organizations (NGOs) may apply. Organizations designated by USAID as public international organizations are also eligible to apply. Issuance of this RFA does not constitute an award commitment on the part of BHA, nor does it commit BHA to pay for costs incurred in the preparation and submission of an application. Applications are submitted at the risk of the applicant. All preparation and submission costs are at the applicant’s expense. This includes the completion of all required documents for USAID awards. All comments and inquiries regarding the FY 2024 IFRP RFA should be addressed to Benjamin C. Vogler at the following address: IFRP@usaid.gov. 

Eligibility: Private voluntary organizations or cooperatives, including U.S. and non-U.S. nongovernmental organizations (NGOs) may apply. Organizations designated by USAID as public international organizations are also eligible to apply.
FY 2024 English Access Scholarship Program
Agency: Bureau Of Educational and Cultural Affairs
Posted: 2024-03-22 | Closing date: 2024-05-28
Award ceiling: 26000000
Award floor: 16000000
Expected number of awards: 1
Cost sharing or matching requirement: No

The English Access Scholarship Program (formerly the English Access Microscholarship Program), established in 2004, is a multifaceted public diplomacy initiative at the forefront of global English language learning and the enhancement of English teaching capacity. With over 200,000 student alumni and over 10,000 teacher alumni in more than 85 countries, the English Access Scholarship Program (Access) is recognized as a high-profile, strategic program that supports U.S. foreign policy objectives, while providing educational opportunities for future leaders globally. Emphasizing critical thinking and employing student-centered and communicative approaches, the program's teaching methodology targets bright, underserved students, primarily aged 13 to 20. The Access Program focuses on four pillars that are integrated into all components of the program: global citizenship themes, 21st-century skills, U.S. culture and values, and communicative English language instruction. The Office of English Language Programs (ECA/A/L), Bureau of Educational and Cultural Affairs anticipates approximately 15,000 participants, including teachers, students, and alumni. Programming may be in-person, virtual, or hybrid and occur in-country, in the region, and in the United States. ECA launched the Access Program in 2004. The program has expanded to become a foundational element in the Bureau’s continuum of exchanges to reach younger and more diverse audiences worldwide. For nearly over a decade, professional development for teachers has also been an integral part of the program. Many Access programs are serving as model classrooms for English teaching in their countries. Only one proposal will be considered by ECA from each applicant organization. In cases where more than one submission from an applicant appears in grants.gov, ECA will only consider the submission made closest in time to the NOFO deadline; that submission would constitute the one and only proposal ECA would review from that applicant. Please see the full announcement for additional information.

Eligibility: Please see full announcement.
Please see full announcement.
Regional Alliances and Multistakeholder Partnerships to Stimulate (RAMPS) Cybersecurity Education and Workforce Development
Agency: National Institute of Standards and Technology
Posted: 2024-03-25 | Closing date: 2024-05-24
Cost sharing or matching requirement: Yes

The NIST National Initiative for Cybersecurity Education (NICE) is seeking applications from eligible applicants for activities to establish community-based partnerships to develop cybersecurity career pathways that address local workforce needs. Effective multistakeholder workforce partnerships will organize multiple employers with skill shortages in specific occupations to focus on developing the skilled workforce to meet industry needs within the local or regional economy.

Eligibility: Eligibility for the program listed in this NOFO is open to all non-Federal entities. Eligible applicants include accredited institutions of higher education; non-profit organizations; for-profit organizations incorporated in the United States; State, local, Territorial, and Indian Tribal governments; foreign public entities; and foreign organizations. Please note that individuals and unincorporated sole proprietors are not considered “non-Federal entities” and are not eligible to apply under this NOFO. Although Federal entities are not eligible to receive funding under this NOFO, they may participate as unfunded collaborators.
DoD Epilepsy Idea Development Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-06-20
Estimated total program funding: 4560000
Expected number of awards: 5
Cost sharing or matching requirement: No

The intent of the FY24 ERP IDA is to solicit novel, innovative research that has the potential to increase our understanding of PTE to improve quality of life, especially in Service Members, Veterans, and/or their care partners. The work should innovatively challenge existing research paradigms or exhibit high levels of creativity. The FY24 ERP IDA offers two levels of funding dependent upon the level of experience of the Principal Investigator (PI). Funding Level I - Pathway to Independence Option: Early-career investigators ranging from the postdoctoral level (e.g., research associate, fellows, residents, or equivalent) to within 3 years of their first independent faculty position (or equivalent) may be named by the organization as the PI on the application (mentor required). Funding Level II - Innovative New Direction Option: Investigators at all career levels may be named by the organization as the PI on the application.
DoD Epilepsy Leveraging Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-06-20
Estimated total program funding: 2400000
Expected number of awards: 3
Cost sharing or matching requirement: No

The intent of the FY24 ERP LRA is to leverage ongoing or completed research studies for which PTE was not an original focus and to provide support to expand the research to develop such a focus and increase our understanding of PTE. The project may include basic, translational, and/or clinical research studies. The study must be associated with an ongoing or completed research effort in which PTE is/was not a research priority and for which addition of cohorts, outcomes, assessments, or analysis specific to PTE would be scientifically justified to increase our understanding of PTE. Examples of allowable research include but are not limited to: Secondary analysis of epilepsy surveillance data to evaluate PTE risk; Addition of a chronic TBI cohort in an ongoing preclinical animal study to evaluate seizure outcomes and epileptogenesis; Recruitment/Analysis of a PTE cohort within an ongoing observational longitudinal study for a known concomitant comorbidity of PTE such as depression, cognitive deficits, sleep disorder, etc.
DOD Amyotrophic Lateral Sclerosis, Clinical Outcomes and Biomarkers Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-07-10
Estimated total program funding: 6100000
Expected number of awards: 5
Cost sharing or matching requirement: No

The FY24 ALSRP Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in Amyotrophic Lateral Sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients.Research may include, but is not limited to:Target engagement biomarkers.Objective pharmacodynamic biomarkers to measure the biological effect of an investigational therapeutic.Predictive/cohort-selective biomarkers that indicate whether a specific therapy will be effective in an individual patient or patient subgroup.Diagnostic, prognostic, or disease progressionValidate clinician-, observer-, patient-reported and/or performance outcomes to better support clinical trial success metrics.Define ALS subtypes using patient-based resources to link biosamples and/or digital data elements to rigorous molecular and clinical data.Realize improved strategies that better measure disease progression for people living with ALS.Augment biospecimens, outcome, or digital health data to an on-going clinical trial.Correlate clinical-trial related data (e.g., biosample, imaging, digital health data) with clinical outcomes or responses to therapies.Use of existing well-characterized and highly curated clinical resources is encouraged. Examples of patient-based ALS resources include ongoing or completed clinical trial datasets, biorepositories of clinical specimens, registries (e.g., Centers for Disease Control and Prevention National ALS Registry and/or Biorepository; https://www.cdc.gov/als/Default.html), large omics datasets, patient-report outcomes, digital biomarker datasets, and databases of clinical data and/or metadata. Active-duty military and/or Veteran patient populations or resources should be considered. A list of suitable resources can be found on the ALSRP web page (https://cdmrp.health.mil/alsrp/resources/ALSRPresources). Other resources may be used, provided they have an adequate description of repository parameters and mechanisms for broad access.
DOD Amyotrophic Lateral Sclerosis, Therapeutic Idea Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-07-10
Estimated total program funding: 9800000
Expected number of awards: 10
Cost sharing or matching requirement: No

The FY24 ALSRP Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at Amyotrophic Lateral Sclerosis (ALS) drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation. Projects that focus primarily on pathophysiology of ALS without development of a therapy are outside the scope of this funding opportunity.Applications may demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis. While the inclusion of preliminary data is not prohibited, the strength of the application should rely on the approach.The key elements of this award mechanism are:Innovation: Research deemed innovative may introduce a new paradigm, challenge current paradigms, introduce novel concepts or technologies, or exhibit other uniquely creative qualities that may lead to potential therapeutics for ALS.Impact: The FY24 TIA can be for a specific ALS subtype and does not have to broadly apply to all patients. Research should be non-incremental and pioneer transformative results that could lay the foundation for a new direction in the field of ALS therapy development. Incremental research does not meet the intent of this funding opportunity.Strong Scientific Rationale: Projects that address in the intent of the mechanism should include a well-formulated, testable hypothesis based on strong scientific rationale that holds translational potential to improve ALS treatment and/or advance a novel treatment modality.Biomarkers: Applicants are required to include consideration to biomarker(s) development in parallel with their proposed Therapeutic Idea Award research for eventual clinical trials. Efforts should be mechanism-specific and may include development of target engagement biomarkers, objective pharmacodynamic biomarkers to measure the biological effect of an investigational therapeutic, or predictive/cohort-selective biomarkers that indicate whether a specific therapy will be effective in an individual patient or patient subgroup, including pre-symptomatic gene carriers. Development of markers for the purposes of diagnosis, prognosis, or measurement of disease progression apart from consideration of the therapeutic development process will not be supported and instead investigators should consider the Clinical Outcomes and Biomarkers Award (HT942524ALSRPCOBA).
DOD Amyotrophic Lateral Sclerosis, Therapeutic Development Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-07-10
Estimated total program funding: 9600000
Expected number of awards: 4
Cost sharing or matching requirement: No

The FY24 ALSRP Therapeutic Development Award supports research ranging from preclinical validation of therapeutic leads through Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed studies are expected to be empirical in nature and product-driven. Applicants with limited ALS experience are strongly encouraged to include collaborators with substantial experience in the relevant ALS model systems, endpoints, and pathophysiology.Applications supported by this award must begin with lead compounds in hand and must include proof-of-concept efficacy data in at least one preclinical model system of ALS, including whole animal and cellular model systems.Examples of activities that will be supported by this award include:Confirmation of candidate therapeutics obtained from screening or by other means, including optimization of potency and pharmacological properties and testing of derivatives and sister compounds.Validation of pilot efficacy studies (such as from an ALSRP Therapeutic Idea Award [TIA]), including the use of additional ALS model systems and/or replicating preliminary data with more time points or additional doses.ND-enabling studies to include: compound characterization; absorption, distribution, metabolism, and excretion (ADME) studies; studies on formulation and stability leading to Good Manufacturing Practice production methods; dose/response and toxicology studies in relevant model systems.Applicants seeking support for basic research focused on ALS drug discovery are encouraged to apply for the FY24 ALSRP TIA (Funding Opportunity Number HT942524 ALSRP TIA), which does not require preliminary data (https://cdmrp.health.mil/funding/alsrp).Mechanism-specific, predictive/cohort-selective, target engagement, and pharmacodynamic biomarker development, in parallel to the main therapeutic effort, is a critical component of the FY24 ALSRP Therapeutic Development Award. If biomarkers are already available or currently in development, how the existing biomarkers will improve trial design, patient selection, and efficiency or interpretation of the proposed ALS therapeutic approach must be apparent in the application. Development of biomarkers for the purposes of diagnosis, prognosis, or measurement of general disease progression without consideration of the therapeutic development process will not be supported. Applicants seeking support for biomarker development independent of therapeutic development are encouraged to apply for the FY24 ALSRP Clinical Outcomes and Biomarkers Award (Funding Opportunity Number HT942524ALSRPCOBA).
DoD Epilepsy Research Partnership Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-06-20
Estimated total program funding: 1920000
Expected number of awards: 1
Cost sharing or matching requirement: No

The intent of the FY24 ERP RPA is to create an avenue to support new or existing collaborative research partnerships between/among investigators to address a research problem or question in a manner that would be unachievable through separate efforts. It is expected that investigators will utilize their distinct but complementary perspectives to synergistically address a central problem or question critical to PTE research and those living with PTE, their families, and/or their care partners.
DoD Epilepsy Virtual Post-Traumatic Epilepsy Research Center – Faculty Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-06-20
Estimated total program funding: 1680000
Expected number of awards: 2
Cost sharing or matching requirement: No

The ERP seeks to solicit Faculty members to join the Virtual Post-Traumatic Epilepsy Research Center (P-TERC) in order to advance PTE research through development of early-career investigators and investigators new to the PTE field. The ERP Virtual P-TERC is a unique, interactive virtual research center providing intensive mentoring, national networking, collaborations, and a peer group for new PTE investigators. The overarching goal of the Virtual P-TERC is to develop successful, highly productive PTE researchers in a collaborative research and career development environment to enhance quality and expand quantity of the PTE research field. The Virtual P-TERC is a multi-institutional career development and research training platform that consists of Faculty and their Career Guides (primary mentors) and is managed by a Director and Deputy Director. The Virtual P-TERC Leadership (the Director and the Deputy Director) serve as a resource for the Faculty and Career Guides, assessing the progress of Faculty and facilitating communication and collaboration among all of the Faculty and Career Guides, as well as with national research societies and representatives from the community with lived PTE experience. In addition to fostering scientific development, the Virtual P-TERC, through its Leadership, provides for professional and leadership development of the Faculty to include skills and competencies needed to fund and manage a productive PTE research laboratory.
Announcement for Program Funding for NRCS’ Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2024 - CONNECTICUT
Agency: Natural Resources Conservation Service
Posted: 2024-03-25 | Closing date: 2024-05-24
Estimated total program funding: 500000
Award ceiling: 250000
Award floor: 20000
Expected number of awards: 3
Cost sharing or matching requirement: Yes

Notice of Funding Opportunity Summary NRCS is announcing the availability of Conservation Innovation Grants (CIG) State Program funding to stimulate the development and adoption of innovative conservation approaches and technologies. Applications are accepted from eligible entities (Section C) for projects carried out in the state of Connecticut. A total of up to $500,000 is available for the Connecticut CIG competition in FY 2024. All non-Foreign, non-federal entities (NFE) and individuals are invited to apply, with the sole exception of federal agencies. Projects may be between one and three years in duration. The maximum award amount for a single award in FY 2024 is $250,000. For new users of Grants.gov, see Section D. of the full Notice of Funding Opportunity for information about steps required before submitting an application via Grants.gov. Completing all steps required to start an application can take a significant amount of time, plan accordingly. Key Dates Applicants must submit their applications via Grants.gov by 11:59 pm Eastern Time on May 24, 2024. For technical issues with Grants.gov, contact Grants.gov Applicant Support at 1-800-518-4726 or support@grants.gov. Awarding agency staff cannot support applicants regarding Grants.gov accounts. For inquiries specific to the content of the NFO requirements, contact the federal awarding agency contact (section G of this NFO). Please limit questions to those regarding specific information contained in this NFO (such as dates, page numbers, clarification of discrepancies, etc.). Questions related to eligibility, or the merits of a specific proposal will not be addressed. The agency anticipates making selections by July 31, 2024 and expects to execute awards by September 15, 2024. These dates are estimates and are subject to change. 

Eligibility: All U.S. non-Foreign, non-Federal entities and individuals are eligible to apply.  US Federal agencies are not eligible to apply to this opportunity or impart their work to non-federal portion of the budget.
DOD FY24 Lung Cancer, Idea Development Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-07
Estimated total program funding: 8400000
Expected number of awards: 10
Cost sharing or matching requirement: No

The FY24 LCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from lung cancer. Research applications only in the area of mesothelioma will not be accepted. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.New Investigators: The FY24 LCRP Idea Development Award mechanism encourages applications from independent investigators in the early stages of their careers (i.e., within 10 years of their first faculty appointment or equivalent). The New Investigator category is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. Applications from New Investigators and Established Investigators will be peer and programmatically reviewed separately. Principal Investigators (PIs) using the New Investigator category are strongly encouraged to strengthen their applications by collaborating with investigators experienced in lung cancer research and/or possessing other relevant expertise. It is the responsibility of the applicant to describe how the included collaboration will augment the PI’s expertise to best address the research question. All applicants for the New Investigator category must meet specific eligibility criteria as described in Section II.C, Eligibility Information.Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of lung cancer.Key elements of this award are as follows:Innovation: Research deemed innovative may introduce a new paradigm, challenge current paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities.Impact: Research that has high potential impact may lead to major advancements and significantly accelerate progress toward eradicating deaths and suffering from lung cancer.It is the responsibility of the PI to clearly and explicitly articulate the project’s innovation and its potential impact on lung cancer and its relevance to Military Health System (MHS) beneficiaries. The project’s impact to both lung cancer research and to patients with lung cancer should be articulated, even if clinical impact is not an immediate outcome. Applications that demonstrate exceptional scientific merit but lack innovation and high potential impact do not meet the intent of the Idea Development Award.
DOD Lung Cancer, Translational Research Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-08-07
Estimated total program funding: 7680000
Expected number of awards: 5
Cost sharing or matching requirement: No

The FY24 LCRP Translational Research Award mechanism supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patient care. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside but can include a reciprocal flow of ideas and information between basic science and clinical science (bench to bedside and/or bedside to bench). Research applications only in the area of mesothelioma will not be accepted. This mechanism is intended to fund a broad range of translational studies with two different funding levels. The following are general examples, although not all-inclusive, of the type of research projects that would be appropriate to propose under the current program announcement:Funding Level 1:• Advanced preclinical studies aimed at translating results from animal studies to applications with human samples/cohorts (The Translational Research Award is not intended to support initial mechanistic studies of a new target.)• Late-stage preclinical work leading to/preparing for a clinical trial, e.g., Investigational New Drug (IND) application submission• Correlative studies that are associated with an open/ongoing or completed clinical trial, e.g., projects that utilize biospecimens from clinical trials to improve clinical management of lung cancer and/or define new areas of research• Projects that develop endpoints for clinical trialsFunding Level 2• Pilot clinical trials where limited clinical testing (e.g., small sample size) of a novel intervention is necessary to inform the next step in the continuum of translational researchPreliminary lung cancer relevant data to support the feasibility of the research hypotheses and research approaches are required.
Ohio Natural Resources Conservation Service Energy Technical Assistance
Agency: Natural Resources Conservation Service
Posted: 2024-03-25 | Closing date: 2024-05-24
Applications must be received by 11:59 pm Eastern Time.
Estimated total program funding: 1500000
Award ceiling: 1500000
Award floor: 100000
Expected number of awards: 2
Cost sharing or matching requirement: No

Notice of Funding Opportunity SummaryThe Natural Resources Conservation Service (NRCS) is directing resources toward climate-smart agriculture and forestry (CSAF) conservation practices, including those for energy efficiency. NRCS is providing funding for a partnership to provide technical assistance to NRCS and producers on energy practices. Information related to NRCS CSAF practices can be found at the following web address: https://www.nrcs.usda.gov/sites/default/files/2023-10/NRCS-CSAF-Mitigation-Activities-List.pdf.A total of up to $1,500,000 is available in fiscal year 2024. All agreements will be five years in duration. Additional funds may be added to agreement in later years as funds become available. Total funding is dependent on the Federal Budget and technical workload in Ohio. For new users of Grants.gov, see Section D. of the full Notice of Funding Opportunity for information about steps required before submitting an application via Grants.gov.Key DatesApplicants must submit their applications via Grants.gov by 11:59 pm Eastern Time on May 24, 2024. For technical issues with Grants.gov, contact Grants.gov Applicant Support at 1-800-518-4726 or support@grants.gov. Awarding agency staff cannot support applicants regarding Grants.gov accounts.For inquiries specific to the content of the NFO requirements, contact the federal awarding agency contact (section G of this NFO). Please limit questions to those regarding specific information contained in this NFO (such as dates, page numbers, clarification of discrepancies, etc.). Questions related to eligibility or the merits of a specific proposal will not be addressed. The agency anticipates making selections by June 24, 2024, and expects to execute awards by July 24, 2024. These dates are estimates and are subject to change.
DOD FY24 Lung Cancer, Career Development Award
Agency: Dept. of the Army -- USAMRAA
Posted: 2024-03-25 | Closing date: 2024-06-17
Estimated total program funding: 1800000
Expected number of awards: 3
Cost sharing or matching requirement: No

The FY24 LCRP Career Development Award supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. Research applications only in the area of mesothelioma will not be accepted. This award is intended to support impactful research projects with an emphasis on discovery.Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated.Key elements of this award are as follows:Principal Investigator (PI): PIs must be research- or physician-scientists at an early stage of their independent research careers. PIs must be within 5 years of their first faculty appointment (or equivalent) and exhibit a strong desire to pursue a career in lung cancer research.Mentorship: The Mentor(s) must be an experienced lung cancer researcher(s) as demonstrated by a strong record of funding and publications in lung cancer research. In addition, the Mentor(s) must demonstrate a commitment to developing the PI’s career in lung cancer research.Career Development: A Career Development Plan is required and should be prepared with appropriate guidance from the Mentor(s). A clearly articulated strategy for acquiring the necessary skills, competence, and expertise to have a career at the forefront of lung cancer research should be included. The plan should outline how the PI will gain experience in lung cancer research. Because career development is the focus of this award, the PI must commit a minimum of a 25% level of time and effort during the period of performance to conduct lung cancer research under this award.Impact: Research that has high potential impact may lead to major advancements and significantly accelerate progress toward eradicating deaths and suffering from lung cancer.Relevance to Military Health System (MHS) Beneficiaries: The application should clearly articulate how the proposed research is relevant to Service Members, Veterans, and their Families.The PI is required to attend a Department of Defense (DOD) one day in progress review meeting prior to the end of the second year of the award.
U.S. Embassy Belmopan PAS Annual Program Statement
Agency: U.S. Mission to Belize
Posted: 2024-04-02 | Closing date: 2024-07-31
Award ceiling: 10000
Award floor: 1000
Expected number of awards: 4
Cost sharing or matching requirement: No

U.S. DEPARTMENT OF STATE U.S. EMBASSY BELMOPAN, PUBLIC AFFAIRS SECTION (PAS) Annual Program Statement Funding Opportunity Title: U.S. Embassy Belmopan PAS Annual Program Statement Funding Opportunity Number: PAS-001-FY2024 Deadline for Applications: May 31, 2024, and July 31, 2024 The Public Affairs Section will accept proposals in two rounds, the first ending May 31, 2024 and the second ending July 31, 2024. Proposals received during Round 1 should plan to start no later than July 2024, and proposals received during round 2 should plan to start no later than September 2024. No applications will be accepted after that date. CFDA Number: 19.040 – Public Diplomacy Programs Total Amount Available: Amount pending funds availability Maximum for Each Award: $10,000 The U.S. Embassy Belmopan Public Affairs Section (PAS) of the U.S. Department of State is pleased to announce that funding is available through its Public Diplomacy Grants Program. This Annual Program Statement (APS) outlines our funding priorities, strategic themes, and the procedures for submitting requests for funding. Applications for programs are accepted on a rolling basis until the deadlines. The deadlines are necessary to provide sufficient time to process and award programs in advance of the end of our fiscal year on September 30, 2024. Purpose of Grants: PAS Belmopan invites proposals for projects that strengthen ties between the United States and Belize by highlighting shared values and promoting bilateral cooperation. Grant proposals must convey an American cultural element, support a priority program area (see below), or include a connection with American experts, organizations, or institutions in a specific field that will promote increased understanding of U.S. policy and perspectives. Please see the full NOFO in the Related Documents folder and carefully follow all instructions to apply. 

Eligibility: Academic, cultural, educational, and other non-profit organizations and/or individuals.
Public Diplomacy